New York healthcare providers who are licensed to prescribe controlled substances, qualified to treat the patient’s condition, and who complete the required OCM-approved course may certify patients for medical cannabis.
Patients use the certification and government-issued ID at a licensed medical dispensary. New York no longer issues separate patient registry ID cards. The primary compliance risk for providers is steering, referral, compensation, website, or registered-organization arrangements that restrict patient choice.
Last legally reviewed: May 12, 2026.
The short answer
In New York, medical cannabis is certified, not prescribed. The certifying provider determines whether medical cannabis is appropriate for the patient. The patient then uses the certification, which includes a registry ID number, with government-issued photo ID to purchase medical cannabis from a licensed medical dispensary.
The provider should not treat the certification as a product sale, dispensary referral, or brand-selection tool.
Who may certify patients in New York
New York OCM states that healthcare providers must have the appropriate practitioner license and DEA registration to lawfully prescribe controlled substances to humans within New York State. Eligible categories include, but are not limited to:
- Physicians.
- Nurse practitioners.
- Physician assistants.
- Dentists.
- Podiatrists.
- Midwives.
Providers must complete at least a two-hour approved course before certifying patients and must use the Medical Cannabis Data Management System within the Health Commerce System.
Scope of the certification
New York allows certification for any condition the provider deems suitable, using professional judgment. The certification may include dosing recommendations, limitations, or other instructions.
Registered organizations must follow the certifying provider’s recommendations or limitations when dispensing to patients.
The certification is not an ordinary prescription. It is the legal gateway into New York’s medical cannabis program.
Patient documentation: no separate registry card
Do not tell New York patients that they will receive or must keep a separate medical cannabis registry card.
OCM states that registry ID cards are no longer issued. The patient certification contains a registry ID number, and the patient uses the certification with a government-issued photo ID at a licensed medical dispensary.
Correct public-facing wording:
New York patients use their medical cannabis certification, which contains a registry ID number, together with government-issued photo ID. New York no longer issues separate patient registry ID cards.
Patient supply
New York patients may purchase up to a 60-day supply of medical cannabis. OCM also describes a quantity framework of 3 ounces of cannabis or 24 grams of concentrate, whichever is greater. The registered organization must follow the certifying provider’s recommendations or limitations.
For provider workflows, document any intended limitations clearly. If the provider wants the dispensing pharmacist or registered organization to exercise discretion within the state framework, the certification should be drafted accordingly.
Anti-steering and patient choice
New York’s anti-steering rules make it one of the most important states for provider-relationship review.
OCM guidance states that a registered organization and associated persons may not enter into agreements with a certifying provider that adversely affect patient choice. OCM also states that websites and healthcare providers associated with websites may not direct patients to a particular registered organization after issuing a certification.
This means New York providers and businesses should review:
- Certification websites.
- Online directories.
- Dispensary locators.
- Paid referral arrangements.
- RO sponsorships or education programs.
- Co-branded marketing.
- Provider compensation tied to patient purchases.
- Lead-generation funnels that send certified patients to a particular RO.
A provider may give general education about medical cannabis, forms, risks, dosage considerations, and safety. The line is crossed when the provider or platform directs the patient to a specific registered organization in a way that impairs patient choice.
Telehealth and certification platforms
New York’s broad provider eligibility and certification structure make telehealth and online workflows attractive. They also create risk.
A compliant New York certification workflow should include:
- Provider licensure and DEA registration screening.
- Required course completion.
- Patient identity verification.
- Clinical intake and condition assessment.
- Documentation of why medical cannabis is appropriate.
- Certification generation through the required state system.
- Patient-choice language.
- No default routing to a particular registered organization.
- Advertising review.
- Compensation review.
Federal Schedule III overlay
The April 2026 federal order does not convert New York medical cannabis certifications into conventional prescriptions for state medical cannabis.
The order places FDA-approved marijuana products and qualifying state-licensed medical marijuana in Schedule III and creates an expedited registration process for covered state medical-marijuana licensees. Adult-use cannabis remains outside that federal medical-marijuana framework.
For New York providers, the practical instruction is: certify within OCM rules, avoid steering, document professional judgment, and keep provider compensation separate from product sales.
Hemp, CBD, and CMS BEI issues
The federal hemp definition changes on November 12, 2026. Many intoxicating hemp products as currently sold are likely to fall outside the federal hemp definition unless reformulated within the new total-THC and cannabinoid limits.
CMS’s Substance Access BEI is optional and limited to approved participants in ACO REACH, EOM, and LEAD. It is not a general Medicare cannabis benefit, and Medicare does not pay the participant for the products.
New York providers discussing hemp or CBD should avoid product steering and should document patient counseling, especially where patients are using intoxicating hemp products outside the regulated medical program.
New York compliance checklist
Before launching or auditing a New York medical cannabis certification workflow, review:
- Provider license category.
- DEA registration to prescribe controlled substances within New York State.
- Required medical cannabis education course completion.
- MCDMS/HCS access and procedures.
- Patient eligibility and clinical judgment documentation.
- Certification template and limitation fields.
- Patient instructions about certification plus government ID.
- Statement that registry ID cards are no longer issued.
- Website language and post-certification flow.
- RO, dispensary, directory, lead-generation, and advertising relationships.
- Patient-choice and anti-steering language.
- Compensation structure.
- Telehealth workflow.
- Collateral-risk counseling.
- Hemp/CBD counseling and November 2026 update plan.
Frequently asked questions
Can New York providers prescribe medical cannabis?
New York providers certify patients for medical cannabis. State medical cannabis is not dispensed through the conventional prescription-pharmacy model.
Who can certify patients in New York?
OCM identifies licensed practitioners with appropriate authority and DEA registration to prescribe controlled substances to humans in New York, including physicians, nurse practitioners, physician assistants, dentists, podiatrists, and midwives, provided they complete the required course and meet program requirements.
Do New York patients receive a registry card?
No. OCM states that registry ID cards are no longer issued. The certification contains the registry ID number and is used with government-issued photo ID.
Can a certification website send patients to a specific dispensary?
New York’s anti-steering rules make this risky. OCM guidance says websites and healthcare providers associated with websites may not direct patients to a particular registered organization after certification.
Did Schedule III change New York certifications into prescriptions?
No. The April 2026 federal order does not turn New York medical cannabis certifications into ordinary controlled-substance prescriptions for state medical cannabis products.
Need Help With New York Medical Cannabis Certification Compliance?
Kocot Law reviews New York medical cannabis certification workflows, telehealth platforms, provider-RO relationships, anti-steering risk, advertising, and healthcare-provider cannabis compliance.
Request a New York anti-steering and certification workflow review before launch.
Primary sources
- New York OCM Medical Cannabis: https://cannabis.ny.gov/medical-cannabis
- New York OCM Healthcare Providers: https://cannabis.ny.gov/practitioners
- New York OCM Medical Cannabis Program FAQs: https://cannabis.ny.gov/medical-cannabis-program-faqs
- New York OCM Patients: https://cannabis.ny.gov/patients
- Federal Register, April 28, 2026 final rule: https://www.federalregister.gov/documents/2026/04/28/2026-08176/schedules-of-controlled-substances-rescheduling-of-food-and-drug-administration-approved-products
- CMS Substance Access BEI: https://www.cms.gov/priorities/innovation/substance-access-beneficiary-engagement-incentive
Disclaimer
This page is for general informational purposes only and does not constitute legal advice. Reading this page or contacting Kocot Law through this website does not create an attorney-client relationship. Cannabis law changes quickly; healthcare professionals and businesses should seek legal advice about their specific facts before acting.
